Buserelin

CAS 57982-77-1

Bucherelin, GnRH analog. At the initial stage of use, the secretion of LH, FSH and sex hormone increased. After 1-2 weeks, the secretion of sex hormone decreased to castration level. It is mainly used in prostate cancer and breast cancer. Subcutaneous injection [with flutamide in men] was used at the beginning, while nasal injection was used for maintenance treatment.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: buserelin-57982-77-1
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Buserelin

CAS 57982-77-1

Bucherelin, GnRH analog. At the initial stage of use, the secretion of LH, FSH and sex hormone increased. After 1-2 weeks, the secretion of sex hormone decreased to castration level. It is mainly used in prostate cancer and breast cancer. Subcutaneous injection [with flutamide in men] was used at the beginning, while nasal injection was used for maintenance treatment.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 57982-77-1
Molecular Formula C60H86N16O13
Molecular Weight 1239.4242
Place of Origin Zhejiang,China (Mainland)
Brand MOSINTER
Density 1.43g/cm3
Request a quote

Send an inquiry for Buserelin

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP